Company profile

PBM

Psyence Biomedical Ltd.

NASDAQHealthcare

End-of-day prices provided by Twelve Data · One close per session. Not real time and not a quote.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

Declared intent to influence

Filed on Schedule 13D: the investor states an intention to influence how the company is run.

Psyence Labs Ltd.30.1%Feb 25, 26SCHEDULE 13D ↗
Psyence Group Inc.15.0%Mar 25, 25SCHEDULE 13D/A ↗
KAOS Capital Ltd.4.9%Jan 8, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Passive holders

Filed on Schedule 13G: large stakes held without an intention to control — mostly index and institutional funds.

Harraden Circle Investments, LLC5.3%Dec 31, 24SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
Hudson Bay Capital Management LP5.0%Mar 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Weiner Jeffrey David2.6%Feb 25, 26SCHEDULE 13G/A ↗1 earlier filing
AdvisorShares Trust0.8%Dec 31, 24SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

145 filings on record, the oldest from Aug 1, 23.

Beta

Scores, historical analogues, watchlist and Radar work over the same companies you can already browse here.

Invite-only beta. Payments are not active yet.